Metabolic & Incretin · Research deep dive
Retatrutide: the cited literature
Every study referenced in the Retatrutide monograph, with plain-language context, PubMed links to read each paper yourself, and how the compound appears in the dosing literature.
How this compound is studied
Across the dosing literature, Retatrutide is studied at 1 mg – 12 mg per administration, typically once weekly. The reference walkthrough below maps each citation to what it actually showed.
References covered
Triple-hormone-receptor agonist retatrutide for obesity (Phase 2)
NEJM, 2023
The full walkthrough is for subscribers
Unlock the evidence grading, what each study actually found, how the trials dosed it, reported safety signals, open questions, and PubMed links for Retatrutide.